Menu
Close
Home
About ImmuneOnco
About Us
Core Team
Development Strategy
ESG Report
Scientific Technology and R&D
Technology Platform
Product Pipeline
Latest Development
Company News
Investor Relations
Information Disclosure
Presentations
Corporate Governance
Investor Calendar
IR Contact
Join Us
Contact Us
Global
CN
TC
Home
CN
TC
About ImmuneOnco
About Us
Core Team
Development Strategy
ESG Report
Scientific Technology and R&D
Technology Platform
Product Pipeline
Scientific News
Company News
Investor Relations
Information Disclosure
Corporate Governance
Investor Calendar
Presentation Materials
Stock Information
Analyst Coverage
IR Contact
Email Subscription Center
Join Us
Contact Us
>
×
Investor Relations
Information Disclosure
Announcements and Circulars
Analyst Report
Financial Reports
Listing Documents
Year
2025
2024
Month
08
06
03
2025-03-17
The top ten biopharma deals of 2024
2025-03-17
Hot PD-(L)1xVEGF Space to Continue Delivering Key Data In '25; TIL Upped to Buy
2024-08-06
ImmuneOnco (1541 HK; NR) - Achieved significant overseas licensing partnership
2024-06-07
ImmuneOnco (1541.HK) Promising results of IMM01 released at ASCO
